Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan-Jun;8(1):57-62.
doi: 10.5005/jp-journals-10018-1260. Epub 2018 May 1.

Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia

Oidov Baatarkhuu  1   2 , Tsagaantsooj Gerelchimeg  1   2 , Dashchirev Munkh-Orshikh  1   2 , Badamnachin Batsukh  1   3 , Ganbold Sarangua  2   3 , Jazag Amarsanaa  2   4
Affiliations
Review

Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia

Oidov Baatarkhuu et al. Euroasian J Hepatogastroenterol. 2018 Jan-Jun.

Abstract

Mongolia is located between Russia and China. The total population of Mongolia as of December 2017 is estimated to be 3.2 million people. According to our previous study results, the prevalence of HBV was 11.8%, and anti-HDV was detected in 4.8% among the HBsAg-positive subjects. Interestingly, most HCV infection is caused by genotype 1b. Among all HBV DNA-positive samples, 98.5% were classified into genotype D, and regarding HDV genotypes, all HDV RNA-positive samples, 100%, were classified into genotype I. The second study is the baseline survey of a Nationwide Cancer Cohort Study. Prevalence of HBsAg was 10.6%. Additionally, HCV infection was observed in 9.9%, and 0.8% were coinfected with HBV and HCV among the general population aged from 10 to 64 years. The third study investigated the population-based prevalence of hepatitis B and C virus in apparently healthy population of Ulaanbaatar city, Mongolia. The anti-HCV prevalence was 9.0%. In addition, the prevalence of HBV was 8.0%. The fourth study is on the prevalence of HCV and coinfections among nurses in a tertiary hospital in Mongolia. The prevalence of HCV was 18.9%. Additionally, HBV infection was observed in 23.1%, and 1.2% were coinfected with HCV and HBV. Mongolia has the highest HCC incidence in the world (78.1/100,000, 3.5* higher than China). As a result, the Mongolia government has launched The National Viral Hepatitis Program, which is a comprehensive program that involves all aspects from prevention to care and disease control to meet a reduction goal for morbidity and mortality due to HBV, HCV, and HDV. Consequently, access to antiviral therapies is now improving in Mongolia. How to cite this article: Baatarkhuu O, Gerelchimeg T, Munkh-Orshikh D, Batsukh B, Sarangua G, Amarsanaa J. Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia. Euroasian J Hepato-Gastroenterol 2018;8(1):57-62.

Keywords: Genotype; Hepatitis B virus; Hepatitis C virus; Hepatitis D virus; Hepatocellular carcinoma; Mongolia; National program..

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

Figures

Graph 1:
Graph 1:
Common causes of mortality 2000-2016
Graph 2:
Graph 2:
Prevalence of hepatitis virus markers in patients with HCC
See this image and copyright information in PMC

References

    1. Walsh, N.; Beckett, G.; Chao, A.; Lo, YR. Viral hepatitis in Mongolia: situation and response. Mongolia: WPRO; 2015 Available from: http://www.wpro.who.int/hepatitis/hepatitis_resource_publication/viral_h...
    1. WPRO. Mongolia reached regional goal on hepatitis B control. Mongolia: WPRO; 2016 [cited 2016 Jun 3]. Available from: http://www.wpro.who.int/mongolia/mediacentre/hepatitis_b_control/en/
    1. Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W et al. Tenofovir to prevent hepatitis Btransmission in mothers with high viral load. N Eng J Med. 2016 Jun;374:2324–2334. - PubMed
    1. Baatarkhuu O, Uugantsetseg G, Munkh-Orshikh D, Naranzul N, Badamjav S, Tserendagva D, Amarsanaa J, Young KD. Viral hepatitis and liver diseases in Mongolia. Euroasian Journal of Hepato-Gastroenterology, January-June. 2017;7(1):69–73. - PMC - PubMed
    1. Davaalkham D, Ojima T, Uehara R, Watanabe M, Oki I, Nymadawa P, Takahashi M, Okamoto H, Nakamura Y. Hepatitis delta virus infection in Mongolia: analyses of geographic distribution, risk factors, and disease severity. Am J Trop Med Hyg. 2006 Aug;75(2):365–369. - PubMed

LinkOut - more resources